Home » Authors » Aaron Lorenzo

Articles by Aaron Lorenzo

MedImmune Sells $500M In Notes, Reports Plan For Stock Buyback

July 11, 2003

By Aaron Lorenzo

PDL Sells $250M In Notes To Pay Down Old Debt, Fund Expansion

July 10, 2003

By Aaron Lorenzo

Protein Design Labs Inc. is planning to replace old debt with new after gaining $250 million through the sale of convertible subordinated notes in a private placement. (BioWorld Today)

PDL Sells $250M In Notes To Pay Down Old Debt, Fund Expansion

July 10, 2003

By Aaron Lorenzo

Protein Design Labs Inc. is planning to replace old debt with new after gaining $250 million through the sale of convertible subordinated notes in a private placement. (BioWorld Today)

AEterna To Raise C$35.6M Upon Entering Bought-Deal Agreement

July 9, 2003

By Aaron Lorenzo

XOMA Regains Full Rights To Neuprex As Baxter Pulls Out

July 9, 2003

By Aaron Lorenzo

XOMA Regains Full Rights To Neuprex As Baxter Pulls Out

July 9, 2003

By Aaron Lorenzo

AEterna To Raise C$35.6M Upon Entering Bought-Deal Agreement

July 9, 2003

By Aaron Lorenzo

NexMed Raises $10.5M Through Private Sale Of Common Shares

July 8, 2003

By Aaron Lorenzo

Cellegy Stock Slides After FDA Issues Non-Approvable Letter

July 8, 2003

By Aaron Lorenzo

Cellegy Stock Slides After FDA Issues Non-Approvable Letter

July 8, 2003

By Aaron Lorenzo